Healthy Vaccinee Bias and MenB-FHbp Vaccine Effectiveness Against Gonorrhea
- PMID: 36863060
- PMCID: PMC10175191
- DOI: 10.1097/OLQ.0000000000001793
Healthy Vaccinee Bias and MenB-FHbp Vaccine Effectiveness Against Gonorrhea
Abstract
Observational studies demonstrated 30% to 40% effectiveness of outer-membrane vesicle (OMV) meningococcal serogroup B vaccines against gonorrhea. To explore whether healthy vaccinee bias influenced such findings, we examined the effectiveness of MenB-FHbp, a non-OMV vaccine that is not protective against gonorrhea. MenB-FHbp was ineffective against gonorrhea. Healthy vaccinee bias likely did not confound earlier studies of OMV vaccines.
Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.
Conflict of interest statement
Conflict of Interest and Sources of Funding: None declared.
References
-
- Kirkcaldy RD, Kidd S, Weinstock HS, et al. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006–June 2012. Sex Transm Infect 2013;89:iv5–iv10. - PubMed
-
- Pérez O, Del Campo J, Cuello M, et al. Mucosal approaches in Neisseria vaccinology. VacciMonitor 2009;18:53–55.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical